CCZ01048 (TFA)

CCZ01048 TFA, a α-MSH analogue, exhibits high binding affinity to melanocortin 1 receptor (MC1R) with a Ki of 0.31 nM. CCZ01048 TFA shows rapid internalization into B16F10 melanoma cells and high in vivo stability. CCZ01048 TFA is a promising candidate for PET imaging of malignant melanoma[1].

Product Specifications

UNSPSC

12352209

Target

Melanocortin Receptor

Type

Peptides

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ccz01048-tfa.html

Purity

98.54

Solubility

DMSO : ≥ 100 mg/mL

Smiles

O=C(N[C@H](C(N[C@H](CC1=CC=CC=C1)C(N[C@H](C(N[C@@H](CC2=CNC3=C2C=CC=C3)C(N[C@@H](CCCCNC4=O)C(N)=O)=O)=O)CCCNC(N)=N)=O)=O)CC5=CN=CN5)[C@H](C4)NC([C@H](CCCC)NC(CN6CCC(NC(CN7CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC7)=O)CC6)=O)=O.OC(C(F)(F)F)=O

Molecular Formula

C73H106F3N21O18

Molecular Weight

1622.75

References & Citations

[1]Zhang C, et al. Preclinical Melanoma Imaging with 68Ga-Labeled α-Melanocyte-Stimulating Hormone Derivatives Using PET. Theranostics. 2017;7 (4) :805-813. Published 2017 Feb 8.